Navigation Links
Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress

= distressing pain, 4 = horrible pain and 5 = excruciating pain. The criteria for pain response are a greater than or equal to 2 point reduction in the patients' weekly PPI score from baseline and maintenance of the two point reduction for at least five consecutive weeks in the setting of a stable or decreasing weekly analgesic score compared to baseline. Patients were evaluable for pain response if their baseline PPI score was greater than or equal to one and had completed four consecutive weekly assessments of PPI and analgesic scores during the study treatment.

Data from the SPARC trial also showed that the prostate specific antigen (PSA) response rate for patients treated with satraplatin was significantly improved compared to the PSA response rate for those patients in the placebo arm. PSA response rates were 25.4 percent for the satraplatin plus prednisone arm compared with 12.4 percent for the placebo arm (p<0.001).

PSA response was analyzed using the widely adopted Bubley criteria of a decrease of PSA level by greater than or equal to 50 percent from baseline, with confirmation at least four weeks later.

"We believe the PSA response rate provides important information especially in this challenging second-line context," said Andrew Allen, Pharmion's chief medical officer and executive vice president. "To see this level of response for both pain and PSA is very encouraging and provides important additional insight on the clinical profile of satraplatin in patients with advanced prostate cancer."

Marcel Rozencweig, M.D., chief medical officer and senior vice president, drug development of GPC Biotech said: "Patients with hormone-refractory prostate cancer frequently suffer from terrible pain associated with bone metastases. The satraplatin data presented today continue to build on the progression-free survival data already presented from the SPARC trial."

The pain and PSA response analyses, in addition to the previously pres
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
2. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
3. Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139 Presented at EULAR
4. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
5. Novel Mechanism Insights and Additional Data on CombinatoRx Drug Candidates to Be Presented at Upcoming EULAR Meeting
6. Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control
7. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
8. Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
10. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
11. Additional Efficacy Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at Annual Meeting of American Urological Association
Post Your Comments:
(Date:7/1/2015)... , July 1, 2015 Prismic Pharmaceuticals, Inc., ... FDA-regulated medical foods, today announced the election of ... to its Board of Directors. Commenting ... Peter Moriarty , Chairman and CEO of Prismic, ... and Martin Simonetti have accepted our invitation ...
(Date:7/1/2015)... YORK, Pa. , July 1, 2015  Unilife ... developer, manufacturer and supplier of injectable drug delivery systems, ... been amended as of June 30, 2015. This amendment ... least $20 million in cash receipts from customers during ... no other adjustments to any of the terms of ...
(Date:7/1/2015)... July 1, 2015  Imprimis Pharmaceuticals, Inc. (NASDAQ: ... the development and commercialization of proprietary compounded drug ... The Nasdaq stock market closing bell on Thursday, ... success of its Go Dropless™ campaign since its ... procedures are performed annually in the U.S. and ...
Breaking Medicine Technology:Joseph Krivulka and Martin Simonetti Join Board of Prismic Pharmaceuticals 2Unilife and OrbiMed Amend Debt Financing Agreement 2Unilife and OrbiMed Amend Debt Financing Agreement 3Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 2Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 3Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 4
... and health care payer and provider organizations convened at the "Selling Pharmaceuticals in 2015" forum in ... drugs on price, features and benefits with a new model that focuses on quantifying and communicating total ... ... , ...
... platform technology designed to standardize hyperthermic perfusion treatments, today announced the appointment of Alan Hirschman , PhD to its Board of Directors. , ... , ... ... ...
Cached Medicine Technology:Drug Makers Discuss New Ways to Trim Health Care Costs at ZS Associates and eyeforpharma Forum 2Drug Makers Discuss New Ways to Trim Health Care Costs at ZS Associates and eyeforpharma Forum 3Drug Makers Discuss New Ways to Trim Health Care Costs at ZS Associates and eyeforpharma Forum 4Drug Makers Discuss New Ways to Trim Health Care Costs at ZS Associates and eyeforpharma Forum 5Drug Makers Discuss New Ways to Trim Health Care Costs at ZS Associates and eyeforpharma Forum 6Drug Makers Discuss New Ways to Trim Health Care Costs at ZS Associates and eyeforpharma Forum 7Drug Makers Discuss New Ways to Trim Health Care Costs at ZS Associates and eyeforpharma Forum 8ThermalTherapeutic Systems, Inc. Announces the Addition of Former MEDRAD Executive Alan Hirschman, PhD to the Board of Directors 2ThermalTherapeutic Systems, Inc. Announces the Addition of Former MEDRAD Executive Alan Hirschman, PhD to the Board of Directors 3
(Date:7/1/2015)... ... - (PRWEB) July 01, 2015 , ... Lisa Keys, the widow of ... August 15-16th (MSG Keys’ birthday) in memory of her late husband and all of ... recipient of the Bronze Star Medal, died during a Special Forces training exercise in ...
(Date:7/1/2015)... ... 2015 , ... Convoy of Hope will partner with local businesses, ... Saturday, August 1, at Spring Lake Park High School. , During the celebration, Convoy ... worth of goods and services including free food, health services, family portraits, job services, ...
(Date:7/1/2015)... ... July 01, 2015 , ... Trevor L. Williams, DMD holds a Bachelor ... at USF earning a Master’s degree in Microbiology. He graduated from the University of ... Dental Association, the Florida Dental Association and the Academy of General Dentistry. Dr. Williams ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... Scoliosis is a disorder in which the ... Scoliosis Foundation, it affects 2 to 3 percent of the population, or an estimated 6 ... often develops in children between the ages of 10 and 15. Most types of scoliosis ...
(Date:7/1/2015)... ... 2015 , ... Franklin University, one of the leading educators of working adults ... named Dean of the College of Health & Public Administration . ... vision and mission of Franklin University via curriculum planning, course scheduling, faculty staffing and ...
Breaking Medicine News(10 mins):Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 2Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 3Health News:Convoy of Hope Hosts Community Event in the Twin Cities 2Health News:Trevor L. Williams, D.M.D. Joins Enlow & Vance Dental Partners in Tampa, Florida 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 3Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 4Health News:Franklin University Appoints Dean of College of Health & Public Administration 2
... the Nebraska Medical AssociationOMAHA, Neb., March 19 With ... three months, it,s time for those who smoke to ... so on Wednesday, March 25, when school children throughout ... sponsored by the Campaign for Tobacco Free Kids. ...
... Company,s Innovative Revenue Cycle OfferingsBOSTON, March 19 ... announced that it has secured $6 million in ... Boston Millennia Partners. This investment will enable MedAptus ... Charge Capture suite of products."The realities of today,s ...
... support and high-risk lifestyles are just some of the ... controlling their condition, according to a research review that ... countries. , The study, published in the March ... of Chronic Illness , shows that psychosocial, socioeconomic, physical, ...
... UL joins the Field Museum for World Water Day March ... world leader in product safety testing services, will launch its ... of the Field Museum, 1400 S. Lake Shore Drive in ... 22, 2009. As part of the organization,s century-long commitment ...
... Syneron(TM) exposed as celebrity beauty secretIRVINE, Calif., March ... the E! show Keeping up with the ... treatment for cellulite reduction and body contouring through ... at 10/9c. In the episode, Khloe prepares ...
... Fallout from 2 studies, pro and con, has experts in ... In the wake of yesterday,s publication of two major studies ... -- one finding that it didn,t save lives and another ... if the test is still worth taking. , The studies, ...
Cached Medicine News:Health News:Kick Butts Day a Timely Prelude to Nebraska's June 1 Smoking Ban 2Health News:MedAptus Secures $6 Million Investment 2Health News:Barriers to diabetes care include restaurants and high-risk lifestyles, says international review 2Health News:Barriers to diabetes care include restaurants and high-risk lifestyles, says international review 3Health News:World Water Day 2009 Marks Launch of UL's Yearlong Commitment to Water Quality and Conservation Education 2Health News:World Water Day 2009 Marks Launch of UL's Yearlong Commitment to Water Quality and Conservation Education 3Health News:Khloe Kardashian Receives Body Contouring VelaShape(TM) Treatment Before Photo Shoot 2Health News:Khloe Kardashian Receives Body Contouring VelaShape(TM) Treatment Before Photo Shoot 3Health News:PSA Testing: What Should Men Do? 2Health News:PSA Testing: What Should Men Do? 3
Inquire...
BD Vacutainer® Specialty Tubes - Acid Citrate Dextrose (ACD)...
BD Vacutainer® Specialty Tubes - Other - Plastic...
BD Vacutainer® Specialty Tubes - Thrombin...
Medicine Products: